The Cluster Headache market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Cluster Headache: An Overview
Cluster Headache is a primary headache disorder and the most common of the group of headache disorders called trigeminal autonomic cephalalgias. The term cluster headache originates from the fact that these attacks occur in groups, or “clusters.” During a cluster cycle, severe headache attacks reappear between 1─8 times per day. Cluster cycles can last for weeks or months and are usually disconnected by remission periods, or periods of headache freedom, which usually last months or years.
Cluster attacks commonly occur overnight, waking people from sleep. People affected with cluster headaches are diagnosed as “episodic” when the attacks occur in periods lasting between 7 days and 1 year and are disjointed by pain-free periods lasting 1 month or longer. In “chronic” cluster headache, attacks occur for more than 1 year without remission or with remissions lasting less than 1 month.
Cluster Headache Market Key Facts
According to Fischera et al., the pooled data for cluster headache showed a lifetime prevalence of 124 per 100,000 and a 1-year prevalence of 53 per 100,000.
According to the research study of Gaul et al., there are approximately 120,000 patients affected by cluster headaches in Germany (Gaul, Diener, & Müller, 2011).
The prevalence of cluster headache on the basis of population-based samples is reported to be 7–119/100, 000 (Gaul et al., 2011).
Cluster Headache Market
Cluster Headache market size is expected to increase during the forecast period owing to the launch of upcoming therapies.
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Cluster Headache market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives a thorough detail of the Cluster Headache market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Cluster Headache Epidemiology
The epidemiology section covers insights about the historical and current Cluster Headache patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Cluster Headache Epidemiology Segmentation –
Total prevalence of Cluster Headache
Gender-specific cases of Cluster Headache
Type-specific cases of Cluster Headache (Episodic Cluster Headache and Chronic Cluster Headache)
Diagnosed and treatable cases of Cluster Headache
Cluster Headache Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cluster Headache market or expected to get launched in the market during the study period. The analysis covers Cluster Headache market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Cluster Headache Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.
Get the PDF Sample of the Report:- https://www.delveinsight.com/sample-request/cluster-headache-market
Cluster Headache Therapeutics Analysis
The dynamics of the Cluster Headache market is expected to change in the coming years owing to the improvement in the diagnosis methodologies, increasing awareness of the disease, and incremental healthcare spending across the world.
Some of the key companies in the Cluster Headache Market include:
Zosano Pharma
Mind Medicine (MindMed)
Eli Lilly and Company
And many others
Cluster Headache Therapies covered in the report include:
LSD
C213 Microneedle System
Emgality (galcanezumab-gnlm)
And many more.
Get More Detailed Insights into the Emerging Therapies & Key Companies:- https://www.delveinsight.com/sample-request/cluster-headache-market
Table of Content
1. Key Insights
2. Executive Summary
3. Cluster Headache Competitive Intelligence Analysis
4. Cluster Headache Market Overview at a Glance
5. Cluster Headache Disease Background and Overview
6. Cluster Headache Patient Journey
7. Cluster Headache Epidemiology and Patient Population
8. Cluster Headache Treatment Algorithm, Current Treatment, and Medical Practices
9. Cluster Headache Unmet Needs
10. Key Endpoints of Cluster Headache Treatment
11. Cluster Headache Marketed Products
12. Cluster Headache Emerging Therapies
13. Cluster Headache Seven Major Market Analysis
14. Attribute Analysis
15. Cluster Headache Market Outlook (7 major markets)
16. Cluster Headache Access and Reimbursement Overview
17. KOL Views on the Cluster Headache Market.
18. Cluster Headache Market Drivers
19. Cluster Headache Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Request Sample Report here:- https://www.delveinsight.com/sample-request/cluster-headache-market
Other Latest Reports By DelveInsight
Bevacizumab Biosimilars Insight
DelveInsight’s, “Bevacizumab Biosimilar Insight” report provides comprehensive insights about 40+ companies and 40+ marketed and pipeline drugs in the Bevacizumab Biosimilars landscape. The report also covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Shruti ThakurEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/
